Glucose starvation greatly enhances antiproliferative and antiestrogenic potency of oligomycin A in MCF-7 breast cancer cells

Capuano, 1997, Oxidative phosphorylation enzymes in normal and neoplastic cell growth, J. Bioenerg. Biomembr., 29, 379, 10.1023/A:1022402915431 Warburg, 1927, The metabolism OF tumors IN the body, J. Gen. Physiol., 8, 519, 10.1085/jgp.8.6.519 Jurisic, 2015, The actual role of LDH as tumor marker, biochemical and clinical aspects, Adv. Exp. Med. Biol., 867, 115, 10.1007/978-94-017-7215-0_8 Radenkovic, 2013, Lactate dehydrogenase, catalase, and superoxide dismutase in tumor tissue of breast cancer patients in respect to mammographic findings, Cell Biochem. Biophys., 66, 287, 10.1007/s12013-012-9482-7 Naik, 2020, Lactate metabolism and immune modulation in breast cancer: a focused review on triple negative breast tumors, Front. Oncol., 10, 598626, 10.3389/fonc.2020.598626 Thakur, 2018, Metformin targets mitochondrial glycerophosphate dehydrogenase to control rate of oxidative phosphorylation and growth of thyroid cancer in vitro and in vivo, clinical cancer research : an, Off. J. Am. Assoc. Canc. Res., 24, 4030, 10.1158/1078-0432.CCR-17-3167 Scherbakov, 2016, The phenomenon of acquired resistance to metformin in breast cancer cells: the interaction of growth pathways and estrogen receptor signaling, IUBMB Life, 68, 281, 10.1002/iub.1481 Kafkova, 2020 Samuel, 2019, Metformin: the answer to cancer in a flower? Current knowledge and future prospects of metformin as an anti-cancer agent in breast cancer, Biomolecules, 9 Berstein, 2011, Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells, Breast Canc. Res. Treat., 128, 109, 10.1007/s10549-010-1072-z Narang, 2019, Recent advancements in mechanistic studies and structure activity relationship of F(o)F(1) ATP synthase inhibitor as antimicrobial agent, Eur. J. Med. Chem., 182, 111644, 10.1016/j.ejmech.2019.111644 Griffiths, 1994, Venturicidin titrates a redox cofactor of mitochondrial ATP synthase, Biochem. Soc. Trans., 22, 321S, 10.1042/bst022321s Lysenkova, 2019, Synthesis, antimicrobial and antiproliferative properties of epi-oligomycin A, the (33S)-diastereomer of oligomycin A, Nat. Prod. Res., 1 Salomon, 2001, Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase, Chem. Biol., 8, 71, 10.1016/S1074-5521(00)00057-0 Vatlin, 2020, Bioinformatic analysis of genes of Streptomyces xinghaiensis (fradiae) ATCC 19609 with a focus on mutations conferring resistance to oligomycin A and its derivatives, J. Global Antimicrob. Resist., 22, 47, 10.1016/j.jgar.2020.01.026 Hearne, 2020, Oligomycin-induced proton uncoupling, Toxicol. Vitro, 104907, 10.1016/j.tiv.2020.104907 Beechey, 1966, Dicyclohexylcarbodiimide--an inhibitor of oxidative phosphorylation, Biochem. Biophys. Res. Commun., 23, 75, 10.1016/0006-291X(66)90271-3 Toei, 2013, Single-molecule analysis of F0F1-ATP synthase inhibited by N,N-dicyclohexylcarbodiimide, J. Biol. Chem., 288, 25717, 10.1074/jbc.M113.482455 Salomon, 2000, Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase, Proc. Natl. Acad. Sci. U.S.A., 97, 14766, 10.1073/pnas.97.26.14766 Serrill, 2015, Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A, Biochem. Pharmacol., 93, 251, 10.1016/j.bcp.2014.11.015 Hao, 2010, Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization, J. Biol. Chem., 285, 12647, 10.1074/jbc.M109.084194 De Luca, 2015, Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells, Oncotarget, 6, 14777, 10.18632/oncotarget.4401 Symersky, 2012, Oligomycin frames a common drug-binding site in the ATP synthase, Proc. Natl. Acad. Sci. U.S.A., 109, 13961, 10.1073/pnas.1207912109 Momose, 2010, Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions, Biochem. Biophys. Res. Commun., 392, 460, 10.1016/j.bbrc.2010.01.050 Danilenko, 2012, vol. 57, 3 Kuznetsov, 2018, New estrogen receptor antagonists. 3,20-Dihydroxy-19-norpregna-1,3,5(10)-trienes: synthesis, molecular modeling, and biological evaluation, Eur. J. Med. Chem., 143, 670, 10.1016/j.ejmech.2017.11.042 Reid, 2003, Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling, Mol. Cell., 11, 695, 10.1016/S1097-2765(03)00090-X Buravchenko, 2020, Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency, Bioorg. Chem., 104, 104324, 10.1016/j.bioorg.2020.104324 Scherbakov, 2017, Steroidal pyrimidines and dihydrotriazines as novel classes of anticancer agents against hormone-dependent breast cancer cells, Front. Pharmacol., 8, 979, 10.3389/fphar.2017.00979 Scherbakov, 2019, Biological evaluation of a new brassinosteroid: antiproliferative effects and targeting estrogen receptor α pathways, Chem. Biodivers., 16, 10.1002/cbdv.201900332 Mruk, 2011, Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits, Spermatogenesis, 1, 121, 10.4161/spmg.1.2.16606 Radde, 2015, Bioenergetic differences between MCF-7 and T47D breast cancer cells and their regulation by oestradiol and tamoxifen, Biochem. J., 465, 49, 10.1042/BJ20131608 Sun, 2015, Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer, J. Bioenerg. Biomembr., 47, 319, 10.1007/s10863-015-9612-1 Parniak, 1985, Incorporation of glucose into glycogen in primary cultures of rat hepatocytes, Canad. J. Biochem. Cell. Biol. = Revue canadienne de biochimie et biologie cellulaire, 63, 333 Zhong, 2009, The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R, J. Biol. Chem., 284, 23225, 10.1074/jbc.M109.005280 Pajak, 2019, 2-Deoxy-d-Glucose and its analogs: from diagnostic to therapeutic agents, Int. J. Mol. Sci., 21, 10.3390/ijms21010234 Hamilton, 2018, Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1, Biochimie, 151, 107, 10.1016/j.biochi.2018.05.012 Cunningham, 2006, Docking studies show that D-glucose and quercetin slide through the transporter GLUT1, J. Biol. Chem., 281, 5797, 10.1074/jbc.M509422200 Coloff, 2011, Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition, Canc. Res., 71, 5204, 10.1158/0008-5472.CAN-10-4531 Isakovic, 2007, Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis, Cell. Mol. Life Sci. : CMLS, 64, 1290, 10.1007/s00018-007-7080-4 Imamura, 2001, Cell cycle regulation via p53 phosphorylation by a 5’-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line, Biochem. Biophys. Res. Commun., 287, 562, 10.1006/bbrc.2001.5627 Zou, 2020, mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges, Cell Biosci., 10, 31, 10.1186/s13578-020-00396-1 Popova, 2021, The role of mTOR signaling as a therapeutic target in cancer, Int. J. Mol. Sci., 22, 10.3390/ijms22041743 Raught, 2001, The target of rapamycin (TOR) proteins, Proc. Natl. Acad. Sci. U.S.A., 98, 7037, 10.1073/pnas.121145898 Raphael, 2020, Everolimus in advanced breast cancer: a systematic review and meta-analysis, Targeted Oncol., 15, 723, 10.1007/s11523-020-00770-6 Bundschuh, 2019, Therapy of patients with neuroendocrine neoplasia-evidence-based approaches and new horizons, J. Clin. Med., 8 Seo, 2003, Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment, Steroids, 68, 257, 10.1016/S0039-128X(02)00179-4 Lardy, 1958, Antibiotics as tools for metabolic studies. I. A survey of toxic antibiotics in respiratory, phosphorylative and glycolytic systems, Arch. Biochem. Biophys., 78, 587, 10.1016/0003-9861(58)90383-7 Racker, 1969, Resolution and reconstitution of a Mammalian membrane, J. Gen. Physiol., 54, 38, 10.1085/jgp.54.1.38 Kobayashi, 1987, A new antitumor antibiotic produced by Streptomyces sp. MCI-2225, J. Antibiot., 40, 1053, 10.7164/antibiotics.40.1053 Mirabelli, 1985, Application of a tissue culture microtiter test for the detection of cytotoxic agents from natural products, J. Antibiot., 38, 758, 10.7164/antibiotics.38.758 Jurisic, 2011, TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells, J. Membr. Biol., 239, 115, 10.1007/s00232-010-9309-7 Ratajczak, 2019, Monitoring of dynamic ATP level changes by oligomycin-modulated ATP synthase inhibition in SW480 cancer cells using fluorescent "On-Off" switching DNA aptamer, Anal. Bioanal. Chem., 411, 6899, 10.1007/s00216-019-02061-0 Souders, 2021, Mitochondria of teleost radial glia: a novel target of neuroendocrine disruption by environmental chemicals?, Comparative biochemistry and physiology, Toxicol. & Pharmacol. : CBP, 243, 108995 Yamazaki, 1992, 44-Homooligomycins A and B, new antitumor antibiotics from Streptomyces bottropensis. Producing organism, fermentation, isolation, structure elucidation and biological properties, J. Antibiot., 45, 171, 10.7164/antibiotics.45.171 Seo, 2003, Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment, Steroids, 68, 257, 10.1016/S0039-128X(02)00179-4 Yang, 2015, Estrogen activates AMP-activated protein kinase in human endothelial cells via ERβ/Ca(2+)/calmodulin-dependent protein kinase kinase β pathway, Cell Biochem. Biophys., 72, 701, 10.1007/s12013-015-0521-z Lipovka, 2014, Estradiol activates AMPK through interaction with extrogen receptor beta (15.4), Faseb. J., 28, 10.1096/fasebj.28.1_supplement.15.4 Kim, 2016, Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines, Oncol. Rep., 35, 2553, 10.3892/or.2016.4675 Lui, 2016, Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells, BMC Canc., 16, 487, 10.1186/s12885-016-2490-z Irwin, 2008, Progesterone and estrogen regulate oxidative metabolism in brain mitochondria, Endocrinology, 149, 3167, 10.1210/en.2007-1227 Wang, 2001, Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells, J. Neurochem., 77, 804, 10.1046/j.1471-4159.2001.00271.x Massart, 2002, Dose-dependent inhibition of mitochondrial ATP synthase by 17 beta-estradiol, Gynecol. Endocrinol. : Off. J. Int. Soc. Gynecol. Endocrinol., 16, 373, 10.1080/gye.16.5.373.377 Varghese, 2019, High glucose represses the anti-proliferative and pro-apoptotic effect of metformin in triple negative breast cancer cells, Biomolecules, 9, 10.3390/biom9010016 Litchfield, 2015, Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer, Oncotarget, 6, 23548, 10.18632/oncotarget.4556 Zhu, 2016, Targeting cancer cell metabolism: the combination of metformin and 2-Deoxyglucose regulates apoptosis in ovarian cancer cells via p38 MAPK/JNK signaling pathway, Am. J. Tourism Res., 8, 4812 Ben Sahra, 2010, Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells, Canc. Res., 70, 2465, 10.1158/0008-5472.CAN-09-2782